Grail and National Health Service (NHS) England Complete Enrollment of 140,000 Participants in Largest Study of Multi-Cancer Early Detection Test

NHS-Galleri Trial is Evaluating Clinical Utility of GRAIL’s Galleri®, a Multi-Cancer Early Detection Test, Alongside Current Standard of Care in England NHS-Galleri Trial Prioritized Equitable Recruitment Approaches Designed to Achieve Representation of People from Minority Ethnic Backgrounds MENLO PARK, Calif.–(BUSINESS WIRE)–GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can … [Read more…]

Alchemy Wellness Resorts to Partner with Premier Brands to Bring Curated Wellness Services to Guests Worldwide

Launch of Pioneering Hospitality and Wellness Management Company, Led by Industry Veterans Patrick Fernandes and Tammy Pahel MIAMI BEACH, Fla.–(BUSINESS WIRE)–Alchemy Wellness Resorts (“Alchemy” or the “Company”) today announced its launch as a pioneering hospitality and wellness management company dedicated to partnering with resorts and brands to bring curated wellness services to more guests worldwide. … [Read more…]

Radialis PET Imager Receives FDA Clearance

Bringing Medical Insight into Focus THUNDER BAY, Ontario–(BUSINESS WIRE)–Radialis Inc. announces it has received FDA clearance to market the Radialis PET Imager, an advanced organ-targeted positron emission tomography (PET) system, in the United States. The heightened sensitivity of the Radialis PET Imager to radiotracer enables the system to produce functional images with high spatial resolution, … [Read more…]

Mycovia Pharmaceuticals Announces U.S. Availability of VIVJOA™ (oteseconazole) Capsules, the First and Only FDA-Approved Medication for Recurrent Vulvovaginal Candidiasis (Chronic Yeast Infection)

VIVJOA is a new option for postmenopausal and permanently infertile women with recurrent vulvovaginal candidiasis (RVVC) VIVJOA is now available in a network of partner pharmacies that includes mail order and local pickup options DURHAM, N.C.–(BUSINESS WIRE)–Mycovia Pharmaceuticals, Inc. (“Mycovia”), an emerging biopharmaceutical company dedicated to recognizing and empowering those living with unmet medical needs … [Read more…]

Imperative Care Announces Poster Presentations on the Zoom Stroke Solution at the Society of NeuroInterventional Surgery 19th Annual Meeting

New, Real-World Data to Provide Insights on the Safety and Efficacy of the Company’s Zoom Family of Products to Treat Ischemic Stroke CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced that new data from studies evaluating the utility of the Zoom Stroke Solution for the treatment of ischemic stroke will be presented at the Society of … [Read more…]

NextGen Healthcare Expands Relationship with InstaMed to Simplify Payment Processing for Patients and Providers

NextGen® Pay powered by InstaMed Provides More Choices for Patients, Better Process for Practices ATLANTA–(BUSINESS WIRE)–$NXGN #NextGenHealthcare–NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of innovative, cloud-based healthcare technology solutions, today announced that it has expanded its long-term relationship with InstaMed, a J.P. Morgan company, in a deal that modernizes payment processing through NextGen® Pay … [Read more…]

Second Sight Medical Products Announces Year Four NIH Funding of its Orion Study

Grant proceeds support an ongoing early feasibility study of Orion LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prostheses that are intended to create an artificial form of useful vision for blind individuals, today announced that the Company received notice from the National … [Read more…]

Global Ambulatory IV infusion Pumps Market Analysis Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Ambulatory IV infusion Pumps Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global ambulatory iv infusion pumps market is expected to grow from $0.75 billion in 2021 to $0.78 billion in 2022 at a compound annual growth rate (CAGR) of 4.5%. The market is expected to grow to $0.89 … [Read more…]

Global Hematology Diagnostic Devices and Equipment Market Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Hematology Diagnostic Devices And Equipment Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global hematology diagnostic devices and equipment market is expected to grow from $1.64 billion in 2021 to $1.91 billion in 2022 at a compound annual growth rate (CAGR) of 16.4%. The market is expected to grow … [Read more…]

The Pharma Mini MBA Training Course (November 9-11, 2022) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “The Pharma Mini MBA Training Course” conference has been added to ResearchAndMarkets.com’s offering. Working in the highly competitive pharmaceutical industry, with ever-increasing change and pressure, is probably one of the most challenging managerial roles of any industry today. This event has been especially designed to help you transcend these challenges by training you … [Read more…]